CompletedPhase 2

HKT-500-US12 In Adult Patients With OA Knee Pain

United States300 participantsStarted 2008-03

Plain-language summary

The objective of this study is to characterize the analgesic properties of single dose study of HKT-500 in subjects with pain caused by mild to moderate OA of the knee

Who can participate

Age range45 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * male or female 45 years of age or older * with osteoarthritis of the knee Exclusion Criteria: * subject is a woman of childbearing potential * who has a positive urine pregnancy test, * is lactating, or who is not surgically sterile

What they're measuring

Time to Onset and Duration

Timeframe: 36 hours

Trial details

NCT IDNCT00647231

SponsorHisamitsu Pharmaceutical Co., Inc.

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2008-08

View on ClinicalTrials.gov More Osteoarthritis, Knee trials